James Kelly Ganjei Net Worth

What's James Ganjei's mailing address?

James's mailing address filed with the SEC is C/O INMUNE BIO INC,, 225 NE MIZNER BLVD., SUITE 640, BOCA RATON,, FL, 33432.

Insiders trading at INmune Bio

Over the last 5 years, insiders at INmune Bio have traded over $5,236,202 worth of INmune Bio stock and bought 82,618 units worth $534,813 . The most active insiders traders include Linda F Powers, Edgardo Jr Baracchini und Inc Xencor. On average, INmune Bio executives and independent directors trade stock every 51 days with the average trade being worth of $117,087. The most recent stock trade was executed by Scott Juda on 25 June 2024, trading 5,000 units of INMB stock currently worth $36,350.

What does INmune Bio do?

INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic syndrome; INB03, an immunotherapy that treats patients with hematologic malignancies and solid tumors; and XPro1595 for the treatment of Alzheimer's disease. The company has license agreements with Xencor, Inc.; Immune Ventures, LLC; University of Pittsburg; and University College London. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.

INmune Bio executives and stock owners

INmune Bio executives and other stock owners filed with the SEC include:

• Dr. Raymond Joseph Tesi M.D.,
  Co-Founder, Pres, CEO, Chief Medical Officer & Chairman
• David J. Moss M.B.A.,
  CFO, Treasurer & Sec.
• Dr. Raymond Joseph Tesi,
  Co-Founder, Pres, CEO, Chief Medical Officer & Chairman
• Dr. Mark William Lowdell BSc, FRCPath, MICR, MSc, Ph.D.,
  Chief Scientific Officer & Chief Manufacturing Officer
• Dr. Mark William Lowdell BSc, MSc, Ph.D., FRCPath, MICR,
  Chief Scientific Officer & Chief Manufacturing Officer
• Dr. Christopher J. Barnum,
  Director of Neuroscience
• Joshua S. Schoonover Esq.,
  Assoc. Gen. Counsel
• Scott Juda,
  Director
• Inc Xencor,
  
• Timothy J Schroeder,
  Director
• Edgardo Jr Baracchini,
  Director
• James Kelly Ganjei,
  Director
• Linda F Powers,
  
• Marcia Allen,
  Director
• Raymond Joseph Tesi,
  President and CEO
• Mark William Lowdell,
  Chief Scientific Officer
• David J Moss,
  Chief Financial Officer